Primary aldosteronism refers to the excess production of the hormone aldosterone from the adrenal glands, resulting in low renin levels. This abnormality is caused by hyperplasia or tumors. Many suffer from fatigue, potassium deficiency and high blood pressure which may cause poor vision, confusion or headaches.

Scope of the Report:

This report studies the Primary Aldosteronism market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Primary Aldosteronism market by product type and applications/end industries.

The treatment for hyperaldosteronism depends on the underlying cause. In people with a single benign tumor (adenoma), surgical removal (adrenalectomy) may be curative. This is usually performed laparoscopically, through several very small incisions. For people with hyperplasia of both glands, successful treatment is often achieved with spironolactone or eplerenone, drugs that block the effect of aldosterone.

The global Primary Aldosteronism market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Primary Aldosteronism.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Pfizer

Sun Pharmaceutical Industries

Bristol Laboratories

CMP Pharma

Koninklijke Philips

GE Healthcare

Siemens

Shimadzu Corporation

Canon

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Type I

Type II

Market Segment by Applications, can be divided into

Hospitals & Clinics

Research Organization

Academic Institutes

Table of Contents

1 Primary Aldosteronism Market Overview

1.1 Product Overview and Scope of Primary Aldosteronism

1.2 Classification of Primary Aldosteronism by Types

1.2.1 Global Primary Aldosteronism Revenue Comparison by Types (2017-2023)

1.2.2 Global Primary Aldosteronism Revenue Market Share by Types in 2017

1.2.3 Type I

1.2.4 Type II

1.3 Global Primary Aldosteronism Market by Application

1.3.1 Global Primary Aldosteronism Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals & Clinics

1.3.3 Research Organization

1.3.4 Academic Institutes

1.4 Global Primary Aldosteronism Market by Regions

1.4.1 Global Primary Aldosteronism Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Primary Aldosteronism Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Primary Aldosteronism Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Primary Aldosteronism Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Primary Aldosteronism Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Primary Aldosteronism Status and Prospect (2013-2023)

1.5 Global Market Size of Primary Aldosteronism (2013-2023)

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Business Overview

2.1.2 Primary Aldosteronism Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer Primary Aldosteronism Revenue, Gross Margin and Market Share (2016-2017)

2.2 Sun Pharmaceutical Industries

2.2.1 Business Overview

2.2.2 Primary Aldosteronism Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sun Pharmaceutical Industries Primary Aldosteronism Revenue, Gross Margin and Market Share (2016-2017)

2.3 Bristol Laboratories

2.3.1 Business Overview

2.3.2 Primary Aldosteronism Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Bristol Laboratories Primary Aldosteronism Revenue, Gross Margin and Market Share (2016-2017)

2.4 CMP Pharma

2.4.1 Business Overview

2.4.2 Primary Aldosteronism Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 CMP Pharma Primary Aldosteronism Revenue, Gross Margin and Market Share (2016-2017)

2.5 Koninklijke Philips

2.5.1 Business Overview

2.5.2 Primary Aldosteronism Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Koninklijke Philips Primary Aldosteronism Revenue, Gross Margin and Market Share (2016-2017)

2.6 GE Healthcare

2.6.1 Business Overview

2.6.2 Primary Aldosteronism Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 GE Healthcare Primary Aldosteronism Revenue, Gross Margin and Market Share (2016-2017)

2.7 Siemens

2.7.1 Business Overview

2.7.2 Primary Aldosteronism Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Siemens Primary Aldosteronism Revenue, Gross Margin and Market Share (2016-2017)

2.8 Shimadzu Corporation

2.8.1 Business Overview

2.8.2 Primary Aldosteronism Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Shimadzu Corporation Primary Aldosteronism Revenue, Gross Margin and Market Share (2016-2017)

2.9 Canon

2.9.1 Business Overview

2.9.2 Primary Aldosteronism Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Canon Primary Aldosteronism Revenue, Gross Margin and Market Share (2016-2017)

3 Global Primary Aldosteronism Market Competition, by Players

3.1 Global Primary Aldosteronism Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Primary Aldosteronism Players Market Share

3.2.2 Top 10 Primary Aldosteronism Players Market Share

3.3 Market Competition Trend

4 Global Primary Aldosteronism Market Size by Regions

4.1 Global Primary Aldosteronism Revenue and Market Share by Regions

4.2 North America Primary Aldosteronism Revenue and Growth Rate (2013-2018)

4.3 Europe Primary Aldosteronism Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Primary Aldosteronism Revenue and Growth Rate (2013-2018)

4.5 South America Primary Aldosteronism Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Primary Aldosteronism Revenue and Growth Rate (2013-2018)

5 North America Primary Aldosteronism Revenue by Countries

5.1 North America Primary Aldosteronism Revenue by Countries (2013-2018)

5.2 USA Primary Aldosteronism Revenue and Growth Rate (2013-2018)

5.3 Canada Primary Aldosteronism Revenue and Growth Rate (2013-2018)

5.4 Mexico Primary Aldosteronism Revenue and Growth Rate (2013-2018)

6 Europe Primary Aldosteronism Revenue by Countries

6.1 Europe Primary Aldosteronism Revenue by Countries (2013-2018)

6.2 Germany Primary Aldosteronism Revenue and Growth Rate (2013-2018)

6.3 UK Primary Aldosteronism Revenue and Growth Rate (2013-2018)

6.4 France Primary Aldosteronism Revenue and Growth Rate (2013-2018)

6.5 Russia Primary Aldosteronism Revenue and Growth Rate (2013-2018)

6.6 Italy Primary Aldosteronism Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Primary Aldosteronism Revenue by Countries

7.1 Asia-Pacific Primary Aldosteronism Revenue by Countries (2013-2018)

7.2 China Primary Aldosteronism Revenue and Growth Rate (2013-2018)

7.3 Japan Primary Aldosteronism Revenue and Growth Rate (2013-2018)

7.4 Korea Primary Aldosteronism Revenue and Growth Rate (2013-2018)

7.5 India Primary Aldosteronism Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Primary Aldosteronism Revenue and Growth Rate (2013-2018)

8 South America Primary Aldosteronism Revenue by Countries

8.1 South America Primary Aldosteronism Revenue by Countries (2013-2018)

8.2 Brazil Primary Aldosteronism Revenue and Growth Rate (2013-2018)

8.3 Argentina Primary Aldosteronism Revenue and Growth Rate (2013-2018)

8.4 Colombia Primary Aldosteronism Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Primary Aldosteronism by Countries

9.1 Middle East and Africa Primary Aldosteronism Revenue by Countries (2013-2018)

9.2 Saudi Arabia Primary Aldosteronism Revenue and Growth Rate (2013-2018)

9.3 UAE Primary Aldosteronism Revenue and Growth Rate (2013-2018)

9.4 Egypt Primary Aldosteronism Revenue and Growth Rate (2013-2018)

9.5 Nigeria Primary Aldosteronism Revenue and Growth Rate (2013-2018)

9.6 South Africa Primary Aldosteronism Revenue and Growth Rate (2013-2018)

10 Global Primary Aldosteronism Market Segment by Type

10.1 Global Primary Aldosteronism Revenue and Market Share by Type (2013-2018)

10.2 Global Primary Aldosteronism Market Forecast by Type (2018-2023)

10.3 Type I Revenue Growth Rate (2013-2023)

10.4 Type II Revenue Growth Rate (2013-2023)

11 Global Primary Aldosteronism Market Segment by Application

11.1 Global Primary Aldosteronism Revenue Market Share by Application (2013-2018)

11.2 Primary Aldosteronism Market Forecast by Application (2018-2023)

11.3 Hospitals & Clinics Revenue Growth (2013-2018)

11.4 Research Organization Revenue Growth (2013-2018)

11.5 Academic Institutes Revenue Growth (2013-2018)

12 Global Primary Aldosteronism Market Size Forecast (2018-2023)

12.1 Global Primary Aldosteronism Market Size Forecast (2018-2023)

12.2 Global Primary Aldosteronism Market Forecast by Regions (2018-2023)

12.3 North America Primary Aldosteronism Revenue Market Forecast (2018-2023)

12.4 Europe Primary Aldosteronism Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Primary Aldosteronism Revenue Market Forecast (2018-2023)

12.6 South America Primary Aldosteronism Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Primary Aldosteronism Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Primary Aldosteronism Picture

Table Product Specifications of Primary Aldosteronism

Table Global Primary Aldosteronism and Revenue (Million USD) Market Split by Prod